Finally, we demonstrate that POL5551 increases sensitivity to cytarabine in a xenograft model of a high-risk pediatric ALL, infant MLL-rearranged (MLL-R) ALL. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.